Baker McKenzie has advised ATB Therapeutics, a Belgian next-generation antibody company, on the successful closing of a 54 million euros Series A financing. With this financing, ATB Therapeutics will advance the development of oncology and immunology
Tags :pharma
Mike Gordon (pictured) is the new group general counsel and executive vice president of Chiesi, international pharma group focused on the research, development and commercialisation of innovative therapeutic solutions in respiratory health, rare diseases and